A C.D.C. panel recommends that other vaccines be preferred over J.&J. by BY REBECCA ROBBINS AND CHRISTINA JEWETT


The agency’s advisers cited concerns about the increased incidence of a rare but potentially serious blood clotting condition among those who received the company’s shot.

Published: December 16, 2021 at 08:11PM

from NYT Health https://ift.tt/3mcGMIj